Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2018, Article ID 3086167, 4 pages

Complications of Diabetes 2017

1Outpatient Clinic of Diabetes, University Hospital of Alexandroupolis, Alexandroupolis, Greece
2Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Łódź, Poland
3Diabetes Center and Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece
4Unit of Diabetes and Cardiovascular Prevention, School of Medicine, University of Palermo, Palermo, Italy
5Diabetic Foot Clinic, King’s College Hospital, London, UK

Correspondence should be addressed to Konstantinos Papatheodorou; rg.oohay@oehtapapk

Received 18 January 2018; Accepted 21 January 2018; Published 11 March 2018

Copyright © 2018 Konstantinos Papatheodorou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 7th edition, 2015.
  2. A. D. Deshpande, M. Harris-Hayes, and M. Schootman, “Epidemiology of diabetes and diabetes-related complications,” Physical Therapy, vol. 88, no. 11, pp. 1254–1264, 2008. View at Publisher · View at Google Scholar
  3. A. Tuttolomondo, C. Maida, and A. Pinto, “Diabetic foot syndrome as a possible cardiovascular marker in diabetic patients,” Journal of Diabetes Research, vol. 2015, Article ID 268390, 12 pages, 2015. View at Publisher · View at Google Scholar
  4. A. Scott, D. Chambers, E. Goyder, and A. O’Cathain, “Socioeconomic inequalities in mortality, morbidity and diabetes management for adults with type 1 diabetes: a systematic review,” PLoS One, vol. 12, no. 5, article e0177210, 2017. View at Publisher · View at Google Scholar
  5. A. R. Shuldiner, R. Yang, and D.-W. Gong, “Resistin, obesity, and insulin resistance — the emerging role of the adipocyte as an endocrine organ,” The New England Journal of Medicine, vol. 345, no. 18, pp. 1345-1346, 2001. View at Publisher · View at Google Scholar
  6. M. Mazidi, P. P. Toth, and M. Banach, “C-reactive protein is associated with prevalence of the metabolic syndrome, hypertension, and diabetes mellitus in US adults,” Angiology, article 331971772928, 2017. View at Publisher · View at Google Scholar
  7. J.-M. V. Niyitegeka, A. C. Bastidas, R. H. Newman, S. S. Taylor, and E. M. Ongeri, “Isoform-specific interactions between meprin metalloproteases and the catalytic subunit of protein kinase A: significance in acute and chronic kidney injury,” American Journal of Physiology‑Renal Physiology, vol. 308, no. 1, pp. F56–F68, 2015. View at Publisher · View at Google Scholar
  8. American Diabetes Association, “10. Microvascular complications and foot care: standards of medical care in diabetes—2018,” Diabetes Care, vol. 41, Supplement 1, pp. S105–S118, 2018. View at Publisher · View at Google Scholar
  9. J. R. W. Brownrigg, N. C. Schaper, and R. J. Hinchliffe, “Diagnosis and assessment of peripheral arterial disease in the diabetic foot,” Diabetic Medicine, vol. 32, no. 6, pp. 738–747, 2015. View at Publisher · View at Google Scholar
  10. A. Goto, O. A. Arah, M. Goto, Y. Terauchi, and M. Noda, “Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis,” BMJ, vol. 347, article f4533, 2013. View at Publisher · View at Google Scholar
  11. M. Peppa, P. Stavroulakis, and S. A. Raptis, “Advanced glycoxidation products and impaired diabetic wound healing,” Wound Repair and Regeneration, vol. 17, no. 4, pp. 461–472, 2009. View at Publisher · View at Google Scholar
  12. L. Li, X. Wan, and G. Zhao, “Meta-analysis of the risk of cataract in type 2 diabetes,” BMC Ophthalmology, vol. 14, no. 1, p. 94, 2014. View at Publisher · View at Google Scholar